Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer.

Takeyama Y, Kato M, Tamada S, Azuma Y, Shimizu Y, Iguchi T, Yamasaki T, Gi M, Wanibuchi H, Nakatani T.

Cancer Lett. 2020 Mar 19;479:89-99. doi: 10.1016/j.canlet.2020.03.013. [Epub ahead of print]

PMID:
32200039
2.

Dimethylarsinic acid (DMA) enhanced lung carcinogenesis via histone H3K9 modification in a transplacental mouse model.

Fujioka M, Suzuki S, Gi M, Kakehashi A, Oishi Y, Okuno T, Yukimatsu N, Wanibuchi H.

Arch Toxicol. 2020 Mar;94(3):927-937. doi: 10.1007/s00204-020-02665-x. Epub 2020 Feb 12.

PMID:
32052077
3.

Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R-CHOP.

Jeon YW, O JH, Park KS, Min GJ, Park SS, Yoon JH, Eom KS, Min CK, Cho SG.

Br J Haematol. 2020 Mar;188(6):860-871. doi: 10.1111/bjh.16257. Epub 2019 Nov 16.

PMID:
31733125
4.

Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage.

Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Lee S.

Cancer Med. 2019 Dec;8(18):7650-7659. doi: 10.1002/cam4.2680. Epub 2019 Nov 5.

5.

Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.

Yukimatsu N, Gi M, Okuno T, Fujioka M, Suzuki S, Kakehashi A, Yanagiba Y, Suda M, Koda S, Nakatani T, Wanibuchi H.

Arch Toxicol. 2019 Dec;93(12):3617-3631. doi: 10.1007/s00204-019-02605-4. Epub 2019 Oct 31.

PMID:
31673724
6.

Experience of blinatumomab salvage for patients with acute lymphoblastic leukemia presenting with isolated extramedullary relapse after previous allogeneic hematopoietic cell transplantation.

Yoon SY, Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Lee JW, Lee S.

Bone Marrow Transplant. 2019 Oct 7. doi: 10.1038/s41409-019-0708-9. [Epub ahead of print] No abstract available.

PMID:
31591448
7.

Long-term administration of excess zinc impairs learning and memory in aged mice.

Yoshida K, Gi M, Fujioka M, Teramoto I, Wanibuchi H.

J Toxicol Sci. 2019;44(10):681-691. doi: 10.2131/jts.44.681.

8.

Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experience.

Jeon YW, Yoon S, Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Lee JW, Cho SG.

Cancer Med. 2019 Nov;8(16):6860-6870. doi: 10.1002/cam4.2565. Epub 2019 Sep 27.

9.

Excellent outcomes of hematopoietic stem cell transplantation with total nodal irradiation and antithymocyte globulin conditioning in severe aplastic anemia with advanced age and/or severe comorbidity.

Park SS, Min GJ, Park S, Lee SE, Yoon JH, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Lee JW.

Bone Marrow Transplant. 2019 Sep 24. doi: 10.1038/s41409-019-0696-9. [Epub ahead of print] No abstract available.

PMID:
31551520
10.

Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia.

Yoon JH, Kim HJ, Min GJ, Park SS, Jeon YW, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW.

Sci Rep. 2019 Aug 15;9(1):11935. doi: 10.1038/s41598-019-47937-4.

11.

A chronic toxicity study of diphenylarsinic acid in the drinking water of C57BL/6J mice for 52 weeks.

Yamaguchi T, Gi M, Fujioka M, Tago Y, Kakehashi A, Wanibuchi H.

J Toxicol Pathol. 2019 Jul;32(3):127-134. doi: 10.1293/tox.2018-0067. Epub 2019 Mar 21.

12.

Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.

Park SS, Cho SY, Han E, Min GJ, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Kim HJ, Min CK, Cho SG, Lee JW.

Eur J Haematol. 2019 Oct;103(4):433-441. doi: 10.1111/ejh.13308. Epub 2019 Aug 21.

PMID:
31381187
13.

Quantitative analysis of mutagenicity and carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in F344 gpt delta transgenic rats.

Gi M, Fujioka M, Totsuka Y, Matsumoto M, Masumura K, Kakehashi A, Yamaguchi T, Fukushima S, Wanibuchi H.

Mutagenesis. 2019 Sep 20;34(3):279-287. doi: 10.1093/mutage/gez015.

PMID:
31233596
14.

Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma.

Jeon YW, Yoon S, Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Lee JW, Cho SG.

Ann Hematol. 2019 Jul;98(7):1743-1753. doi: 10.1007/s00277-019-03714-x. Epub 2019 May 14.

15.

Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Jeon YW, Yoon S, Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Lee JW, Cho SG.

Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):345-355.e7. doi: 10.1016/j.clml.2019.03.023. Epub 2019 Mar 30.

16.

Acetoaceto-o-Toluidide Enhances Cellular Proliferative Activity in the Urinary Bladder of Rats.

Okuno T, Gi M, Fujioka M, Yukimatu N, Kakehashi A, Takeuchi A, Endo G, Endo Y, Wanibuchi H.

Toxicol Sci. 2019 Jun 1;169(2):456-464. doi: 10.1093/toxsci/kfz051.

PMID:
30796441
17.

Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia.

Kim TW, Park SS, Lim JY, Min GJ, Park S, Jeon YW, Yahng SA, Shin SH, Lee SE, Yoon JH, Cho BS, Eom KS, Lee S, Kim HJ, Min CK.

Int J Stem Cells. 2018 Dec 31;12(1):73-83. doi: 10.15283/ijsc18094.

18.

Steroid sulfatase promotes invasion through epithelial-mesenchymal transition and predicts the progression of bladder cancer.

Shimizu Y, Tamada S, Kato M, Takeyama Y, Fujioka M, Kakehashi A, Nakatani T, Wanibuchi H, Gi M.

Exp Ther Med. 2018 Dec;16(6):4463-4470. doi: 10.3892/etm.2018.6787. Epub 2018 Sep 21.

19.

Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia.

Yoon JH, Min GJ, Park SS, Jeon YW, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Lee S.

Cancer. 2019 Mar 15;125(6):873-883. doi: 10.1002/cncr.31874. Epub 2018 Dec 6.

20.

mTOR Activation in Liver Tumors Is Associated with Metabolic Syndrome and Non-Alcoholic Steatohepatitis in Both Mouse Models and Humans.

Okuno T, Kakehashi A, Ishii N, Fujioka M, Gi M, Wanibuchi H.

Cancers (Basel). 2018 Nov 22;10(12). pii: E465. doi: 10.3390/cancers10120465.

Supplemental Content

Loading ...
Support Center